Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-25-005562
Filing Date
2025-02-24
Accepted
2025-02-24 07:01:28
Documents
184
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 20-F ef20038762_20f.htm   iXBRL 20-F 7577028
2 EXHIBIT 2.3 ef20038762_ex2-3.htm EX-2.3 105228
3 EXHIBIT 4.8 ef20038762_ex4-8.htm EX-4.8 355028
4 EXHIBIT 4.18 ef20038762_ex4-18.htm EX-4.18 36230
5 EXHIBIT 4.19 ef20038762_ex4-19.htm EX-4.19 119635
6 EXHIBIT 8.1 ef20038762_ex8-1.htm EX-8.1 27283
7 EXHIBIT 11.1 ef20038762_ex11-1.htm EX-11.1 127435
8 EXHIBIT 12.1 ef20038762_ex12-1.htm EX-12.1 13104
9 EXHIBIT 12.2 ef20038762_ex12-2.htm EX-12.2 12793
10 EXHIBIT 13.1 ef20038762_ex13-1.htm EX-13.1 5263
11 EXHIBIT 13.2 ef20038762_ex13-2.htm EX-13.2 5163
12 EXHIBIT 15.1 ef20038762_ex15-1.htm EX-15.1 2185
18 image00002.jpg GRAPHIC 4072
19 pipelinegraphicfeb22.jpg GRAPHIC 525814
  Complete submission text file 0001140361-25-005562.txt   33176544

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA tlx-20241231.xsd EX-101.SCH 186211
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tlx-20241231_cal.xml EX-101.CAL 164992
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tlx-20241231_def.xml EX-101.DEF 721009
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE tlx-20241231_lab.xml EX-101.LAB 1807762
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tlx-20241231_pre.xml EX-101.PRE 1085384
187 EXTRACTED XBRL INSTANCE DOCUMENT ef20038762_20f_htm.xml XML 7544151
Mailing Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051
Business Address 55 FLEMINGTON ROAD NORTH MELBOURNE C3 3051 61 3 9093 3855
Telix Pharmaceuticals Ltd (Filer) CIK: 0002007191 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-42128 | Film No.: 25654146
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)